Published in Biochem J on December 01, 1994
Protein kinase C isoforms epsilon, eta, delta and zeta in murine adipocytes: expression, subcellular localization and tissue-specific regulation in insulin-resistant states. Biochem J (1996) 1.04
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors. Cancer Chemother Pharmacol (2009) 0.87
Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues. PLoS Comput Biol (2011) 0.86
OX1 orexin/hypocretin receptor activation of phospholipase D. Br J Pharmacol (2012) 0.77
The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature (1988) 14.43
Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (1992) 12.18
Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem (1993) 7.16
Calcium-activated, phospholipid-dependent protein kinase from rat brain. Subcellular distribution, purification, and properties. J Biol Chem (1982) 3.64
A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominantly expressed in lung and skin. J Biol Chem (1990) 2.12
Purification to homogeneity of protein kinase C from bovine brain--identity with the phorbol ester receptor. EMBO J (1984) 1.97
Phospholipid-sensitive Ca2+-dependent protein kinase from heart. I. Purification and general properties. J Biol Chem (1982) 1.88
Purification and characterization of the zeta isoform of protein kinase C from bovine kidney. J Biol Chem (1992) 1.66
Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis (1987) 1.44
Isolation and characterization of the epsilon subspecies of protein kinase C from rat brain. Proc Natl Acad Sci U S A (1992) 1.22
Expression of protein kinase C isotypes using baculovirus vectors. Methods Enzymol (1991) 1.20
The potential of protein kinase C as a target for anticancer treatment. Pharmacol Ther (1993) 1.19
Isolation and characterization of delta-subspecies of protein kinase C from rat brain. Proc Natl Acad Sci U S A (1992) 1.18
Mutagenesis of the regulatory domain of rat protein kinase C-eta. A molecular basis for restricted histone kinase activity. J Biol Chem (1993) 1.08
Protein kinase C zeta and eta in murine epidermis. TPA induces down-regulation of PKC eta but not PKC zeta. FEBS Lett (1992) 1.08
Predominant expression of nPKC eta, a Ca(2+)-independent isoform of protein kinase C in epithelial tissues, in association with epithelial differentiation. Cell Growth Differ (1993) 1.02
Protein kinase C group B members PKC-delta, -epsilon, -zeta and PKC-L(eta). Comparison of properties of recombinant proteins in vitro and in vivo. Biochem J (1992) 1.01
Biochemical properties of rat protein kinase C-eta expressed in COS cells. FEBS Lett (1992) 0.96
Purification and characterization of protein kinase C epsilon from rabbit brain. Biochemistry (1992) 0.96
Staurosporine-related compounds, K252a and UCN-01, inhibit both cPKC and nPKC. FEBS Lett (1993) 0.89
Differentiative action of K252a on protein kinase C and a calcium-unresponsive, phorbol ester/phospholipid-activated protein kinase. Biochem Biophys Res Commun (1989) 0.87
Purification and characterization of a calcium-unresponsive, phorbol ester/phospholipid-activated protein kinase from porcine spleen. J Biol Chem (1990) 0.86
Differentiation-associated localization of nPKC eta, a Ca(++)-independent protein kinase C, in normal human skin and skin diseases. J Invest Dermatol (1993) 0.85
Immunological demonstration of epsilon PKC. Murine tissue distribution, ontogeny, cellular localization and translocation. FEBS Lett (1991) 0.80
A phorbol ester and phospholipid-activated, calcium-unresponsive protein kinase in mouse epidermis: characterization and separation from protein kinase C. J Cell Biochem (1989) 0.80
Differential inhibition by staurosporine of phorbol ester, bryostatin and okadaic acid effects on mouse skin. Cancer Lett (1992) 0.79
Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun (1994) 4.60
Protein kinase C activation by phorbol esters: do cysteine-rich regions and pseudosubstrate motifs play a role? Trends Biochem Sci (1991) 1.65
Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3. Am J Hum Genet (1994) 1.64
Searching for unknown feature targets on more than one dimension: investigating a "dimension-weighting" account. Percept Psychophys (1996) 1.60
Molecular cloning of mouse protein kinase C (PKC) cDNA from Swiss 3T3 fibroblasts. Gene (1988) 1.57
Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K protein. J Biol Chem (1999) 1.50
Role of tyrosine phosphorylation in the regulation of the interaction of heterogenous nuclear ribonucleoprotein K protein with its protein and RNA partners. J Biol Chem (2000) 1.44
A developmental study of the distribution and frequency of Langerhans cells in relation to formation of patterning in mouse tail epidermis. J Invest Dermatol (1977) 1.44
Endovascular treatment of subclavian pseudoaneurysm causing delayed brachial plexus paralysis. Vasa (2004) 1.40
Phosphorylation of protein kinase Cdelta (PKCdelta) at threonine 505 is not a prerequisite for enzymatic activity. Expression of rat PKCdelta and an alanine 505 mutant in bacteria in a functional form. J Biol Chem (1997) 1.35
Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci U S A (2001) 1.21
Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res (1998) 1.21
The effect of the New York State restrictions on resident work hours. Obstet Gynecol (1991) 1.20
Characterization of an 8-lipoxygenase activity induced by the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin in vivo. J Biol Chem (1991) 1.17
Molecular cloning of sequences activated during multi-stage carcinogenesis in mouse skin. Carcinogenesis (1986) 1.15
Conventional PKC-alpha, novel PKC-epsilon and PKC-theta, but not atypical PKC-lambda are MARCKS kinases in intact NIH 3T3 fibroblasts. J Biol Chem (1997) 1.14
Idiotypic selection of an antibody mutant with changed hapten binding specificity, resulting from a point mutation in position 50 of the heavy chain. EMBO J (1986) 1.12
Skin tumor promotion by phorbol esters is a two-stage process. Proc Natl Acad Sci U S A (1981) 1.10
Tyrosine phosphorylation and stimulation of protein kinase C delta from porcine spleen by src in vitro. Dependence on the activated state of protein kinase C delta. FEBS Lett (1994) 1.09
Protein kinase C zeta and eta in murine epidermis. TPA induces down-regulation of PKC eta but not PKC zeta. FEBS Lett (1992) 1.08
Protein-kinase-Cmu expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture. Int J Cancer (1999) 1.08
The effect of visual attention on peripheral discrimination thresholds in single and multiple element displays. Acta Psychol (Amst) (1988) 1.07
Requirements of protein kinase cdelta for catalytic function. Role of glutamic acid 500 and autophosphorylation on serine 643. J Biol Chem (1999) 1.07
Specific binding of estradiol to the liver chromatin of estrogenized roosters. Biochim Biophys Acta (1974) 1.05
Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin. Int J Cancer (1999) 1.05
Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2. Mol Carcinog (1998) 1.05
Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A 23187 and by tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1981) 1.05
Inhibition of the calcium- and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin. Biochem Biophys Res Commun (1983) 1.03
Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol Carcinog (1995) 1.02
Indomethacin inhibition of cell proliferation induced by the phorbolester TPA is reversed by prostaglandin E2 in mouse epidermis in vivo. Biochem Biophys Res Commun (1978) 1.02
Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols. Br J Haematol (1999) 1.01
Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc Natl Acad Sci U S A (1993) 1.01
Ornithine decarboxylase activity, cell proliferation, and tumor promotion in mouse epidermis in vivo. Cancer Res (1979) 1.01
Activation of cytosolic phospholipase A2 by transforming growth factor-alpha in HEL-30 keratinocytes. J Biol Chem (1993) 1.00
cDNA cloning, genomic structure, and chromosomal localization of a novel murine epidermis-type lipoxygenase. Genomics (1999) 0.99
Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. Gut (2001) 0.99
The neural basis of ego- and allocentric reference frames in spatial navigation: evidence from spatio-temporal coupled current density reconstruction. Brain Res (2006) 0.99
A gene cluster encoding human epidermis-type lipoxygenases at chromosome 17p13.1: cloning, physical mapping, and expression. Genomics (2001) 0.99
Arachidonic acid and prostaglandin E2 release and enhanced cell proliferation induced by the phorbol ester TPA in a murine epidermal cell line. Cancer Lett (1981) 0.99
Effect of tumor-promoting phorbol esters and of acetic acid on mechanisms controlling DNA synthesis and mitosis (Chalones) and on the biosynthesis of histidine-rich protein in mouse epidermis. Cancer Res (1974) 0.99
Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system. Br J Haematol (2001) 0.98
Top-down controlled visual dimension weighting: an event-related fMRI study. Cereb Cortex (2002) 0.98
A fronto-posterior network involved in visual dimension changes. J Cogn Neurosci (2000) 0.98
Risk factors for Japanese encephalitis: a case-control study. Epidemiol Infect (2010) 0.98
Sensitivity and criterion effects in the spatial cuing of visual attention. Percept Psychophys (1987) 0.97
Visual search for dimensionally redundant pop-out targets: evidence for parallel-coactive processing of dimensions. Percept Psychophys (2001) 0.97
Early prostaglandin E synthesis is an obligatory event in the induction of cell proliferation in mouse epidermis in vivo by the phorbol ester TPA. Biochem Biophys Res Commun (1980) 0.97
Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine. FEBS Lett (1994) 0.97
Positional- and stereo-selectivity of fatty acid oxygenation catalysed by mouse (12S)-lipoxygenase isoenzymes. Biochem J (2000) 0.96
The induction of ornithine decarboxylase by the tumor promoter TPA is controlled at the post-transcriptional level in murine Swiss 3T3 fibroblasts. Biochem Biophys Res Commun (1987) 0.96
Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1H-n.m.r. and GC-MS spectroscopy. Carcinogenesis (1986) 0.96
Pressure variation of the lateral diffusion in lipid bilayer membranes. Biochim Biophys Acta (1983) 0.96
The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells. J Biol Chem (1996) 0.96
The mouse ear edema: a quantitatively evaluable assay for tumor promoting compounds and for inhibitors of tumor promotion. Cancer Lett (1984) 0.95
The effect of indomethacin on cell proliferation induced by chemical and mechanical means in mouse epidermis in vivo. Res Commun Chem Pathol Pharmacol (1979) 0.95
Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. Am J Gastroenterol (2001) 0.94
Purification and properties of oestradiol 17 beta-dehydrogenase extracted from cytoplasmic vesicles of porcine endometrial cells. Biochem J (1992) 0.94
Protein kinase C delta-specific phosphorylation of the elongation factor eEF-alpha and an eEF-1 alpha peptide at threonine 431. J Biol Chem (1995) 0.94
Repetin (Rptn), a new member of the "fused gene" subgroup within the S100 gene family encoding a murine epidermal differentiation protein. Genomics (1997) 0.94
Residency training in contraception, sterilization, and abortion. Obstet Gynecol (1993) 0.93
Immunological demonstration of a calcium-unresponsive protein kinase C of the delta-type in different species and murine tissues. Predominance in epidermis. J Biol Chem (1991) 0.93
Expression of Plasmodium falciparum 3D7 STEVOR proteins for evaluation of antibody responses following malaria infections in naïve infants. Parasitology (2007) 0.92
Chain length and pressure dependence of lipid translational diffusion. Eur Biophys J (1987) 0.92
Decreased protein kinase C activity in psoriatic versus normal epidermis. J Invest Dermatol (1987) 0.92
Stimulatory role of transforming growth factors in multistage skin carcinogenesis: possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skin. Int J Cancer (1989) 0.92
Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet (1995) 0.92
Right ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J (1997) 0.92
Cyclic 3', 5'-AMP and theophylline inhibit epidermal mitosis in G2-phase. Naturwissenschaften (1972) 0.91
Regulation of protein kinase Cmu by basic peptides and heparin. Putative role of an acidic domain in the activation of the kinase. J Biol Chem (1997) 0.91
Epidermal growth control mechanisms, hyperplasia, and tumor promotion in the skin. Cancer Res (1976) 0.91
DIK, a novel protein kinase that interacts with protein kinase Cdelta. Cloning, characterization, and gene analysis. J Biol Chem (2000) 0.90
Pre-treatment with chloroquine and parasite chloroquine resistance in Ghanaian children with severe malaria. QJM (2005) 0.90
Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). Carcinogenesis (1989) 0.90
Enzymic characterization of epidermis-derived 12-lipoxygenase isoenzymes. Biochem J (2001) 0.90
Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J Biol Chem (1995) 0.89
cDNA cloning of a 8-lipoxygenase and a novel epidermis-type lipoxygenase from phorbol ester-treated mouse skin. Biochim Biophys Acta (1998) 0.89
Protein kinase C delta accepts GTP for autophosphorylation. Biochem Biophys Res Commun (1995) 0.89
Effect of foetal calf serum and epidermal growth factor on DNA synthesis in explants of chick embryo epidermis. Nature (1974) 0.89
Tumor-promoting compounds from Euphorbia cooperi di- and triesters of 16-hydroxy-12-desoxy-phorbol. Tetrahedron Lett (1970) 0.89
Murine 12(R)-lipoxygenase: functional expression, genomic structure and chromosomal localization. FEBS Lett (1999) 0.88
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries. Br J Clin Pharmacol (2001) 0.88
Immunological demonstration of protein kinase C mu in murine tissues and various cell lines. Differential recognition of phosphorylated forms and lack of down-regulation upon 12-O-tetradecanoylphorphol-13-acetate treatment of cells. Eur J Biochem (1996) 0.88
Expression of PGF(2alpha) receptor mRNA in normal, hyperplastic and neoplastic skin. Carcinogenesis (2000) 0.88
Anaerobic exercise induces moderate acute phase response. Med Sci Sports Exerc (2001) 0.88